Coenzyme Total Assets from 2010 to 2026
| PPII Stock | USD 0.0002 0.00 0.00% |
Total Assets | First Reported 2010-12-31 | Previous Quarter 71.2 K | Current Value 70.6 K | Quarterly Volatility 5.4 K |
Check Coenzyme A financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Coenzyme A's main balance sheet or income statement drivers, such as Interest Expense of 0.0, Selling General Administrative of 272.8 K or Total Revenue of 316.4 K, as well as many indicators such as . Coenzyme financial statements analysis is a perfect complement when working with Coenzyme A Valuation or Volatility modules.
Coenzyme | Total Assets | Build AI portfolio with Coenzyme Stock |
The Total Assets trend for Coenzyme A offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Coenzyme A is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Coenzyme A's Total Assets Growth Pattern
Below is the plot of the Total Assets of Coenzyme A over the last few years. Total assets refers to the total amount of Coenzyme A assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Coenzyme A books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Coenzyme A's Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Coenzyme A's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 79.08 K | 10 Years Trend |
|
Total Assets |
| Timeline |
Coenzyme Total Assets Regression Statistics
| Arithmetic Mean | 79,196 | |
| Geometric Mean | 79,034 | |
| Coefficient Of Variation | 6.85 | |
| Mean Deviation | 2,143 | |
| Median | 79,082 | |
| Standard Deviation | 5,421 | |
| Sample Variance | 29.4M | |
| Range | 26.8K | |
| R-Value | (0.62) | |
| Mean Square Error | 19.4M | |
| R-Squared | 0.38 | |
| Significance | 0.01 | |
| Slope | (661.43) | |
| Total Sum of Squares | 470.2M |
Coenzyme Total Assets History
About Coenzyme A Financial Statements
Investors use fundamental indicators, such as Coenzyme A's Total Assets, to determine how well the company is positioned to perform in the future. Although Coenzyme A's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
| Last Reported | Projected for Next Year | ||
| Total Assets | 71.2 K | 70.6 K |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out the analysis of Coenzyme A Correlation against competitors. For more detail on how to invest in Coenzyme Stock please use our How to Invest in Coenzyme A guide.You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Is there potential for Pharmaceuticals market expansion? Will Coenzyme introduce new products? Factors like these will boost the valuation of Coenzyme A. Anticipated expansion of Coenzyme directly elevates investor willingness to pay premium valuations. Understanding fair value requires weighing current performance against future potential. All the valuation information about Coenzyme A listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (35.31) | Revenue Per Share 2.652 | Quarterly Revenue Growth 0.268 |
Coenzyme A's market price often diverges from its book value, the accounting figure shown on Coenzyme's balance sheet. Smart investors calculate Coenzyme A's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Since Coenzyme A's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Coenzyme A's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Coenzyme A should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Coenzyme A's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.